Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants
暂无分享，去创建一个
H. van Bakel | Shinji Watanabe | Y. Kawaoka | P. Halfmann | V. Simon | A. Pekosz | S. Fukushi | M. Imai | Tadaki Suzuki | H. Hasegawa | Mutsumi Ito | S. Yamayoshi | Y. Sakai-Tagawa | E. Sordillo | E. Takashita | Ken Maeda | Yuko Sakai-Tagawa
[1] P. Maes,et al. Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies , 2022, Nature Medicine.
[2] Liyuan Liu,et al. Antibody evasion properties of SARS-CoV-2 Omicron sublineages , 2022, Nature.